Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors
- 1 March 2015
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 38 (3), E12
- https://doi.org/10.3171/2014.12.focus14748
Abstract
Chloroquine (CQ) is a quinoline-based drug widely used for the prevention and treatment of malaria. More recent studies have provided evidence that this drug may also harbor antitumor properties, whereby CQ possesses the ability to accumulate in lysosomes and blocks the cellular process of autophagy. Therefore, the authors of this study set out to investigate whether CQ analogs, in particular clinically established antimalaria drugs, would also be able to exert antitumor properties, with a specific focus on glioma cells.Toward this goal, the authors treated different glioma cell lines with quinine (QN), quinacrine (QNX), mefloquine (MFQ), and hydroxychloroquine (HCQ) and investigated endoplasmic reticulum (ER) stress-induced cell death, autophagy, and cell death.All agents blocked cellular autophagy and exerted cytotoxic effects on drug-sensitive and drug-resistant glioma cells with varying degrees of potency (QNX > MFQ > HCQ > CQ > QN). Furthermore, all quinoline-based drugs killed glioma cells that were highly resistant to temozolomide (TMZ), the current standard of care for patients with glioma. The cytotoxic mechanism involved the induction of apoptosis and ER stress, as indicated by poly(ADP-ribose) polymerase (PARP) cleavage and CHOP/GADD153. The induction of ER stress and resulting apoptosis could be confirmed in the in vivo setting, in which tumor tissues from animals treated with quinoline-based drugs showed increased expression of CHOP/GADD153, along with elevated TUNEL staining, a measure of apoptosis.Thus, the antimalarial compounds investigated in this study hold promise as a novel class of autophagy inhibitors for the treatment of newly diagnosed TMZ-sensitive and recurrent TMZ-resistant gliomas.Keywords
This publication has 39 references indexed in Scilit:
- Cell death and autophagy: Cytokines, drugs, and nutritional factorsToxicology, 2008
- Mefloquine-Induced Disruption of Calcium Homeostasis in Mammalian Cells Is Similar to That Induced by IonomycinAntimicrobial Agents and Chemotherapy, 2008
- Modulating Autophagy for Therapeutic BenefitAutophagy, 2007
- Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiformeSurgical Neurology, 2007
- Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphomaJCI Insight, 2007
- Effectiveness of Antimalarial DrugsThe New England Journal of Medicine, 2005
- Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in miceBritish Journal of Pharmacology, 2004
- Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial DrugsClinical Pharmacokinetics, 2003
- Present Trends and Future Strategy in Chemotherapy of MalariaCurrent Medicinal Chemistry, 2001
- Interaction of Chloroquine and Its Analogues with Heme: An Isothermal Titration Calorimetric StudyBiochemical and Biophysical Research Communications, 2000